Ryo Nishikawa

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 16, 2026
Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial.

Francesco Sanvito, Catalina Raymond, Donatello Telesca

|Jan 28, 2026
Safety and Efficacy of Tumor-Treating Fields (TTFields) Therapy for Pediatric High-Grade Glioma: Results of a Prespecified Interim Analysis of the First Three Cases.

Atsushi Makimoto, Keita Terashima, Ryo Nishikawa

|Nov 04, 2024
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study.

Hirokazu Takami, Masao Matsutani, Tomonari Suzuki

|May 01, 2024
Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma.

Hajime Yonezawa, Yoshitaka Narita, Motoo Nagane

|Apr 26, 2024
Successful Multimodal Treatment of Intracranial Growing Teratoma Syndrome with Malignant Features.

Daiken Satake, Manabu Natsumeda, Kaishi Satomi

|Sep 25, 2023
Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinib.

Yoshiki Arakawa, Yoshitaka Narita, Motoo Nagane

Pageof 2

Frequent Collaborators

5 joint publications

Yoshitaka Narita

5 joint publications

Yoshiki Arakawa

3 joint publications

Motoo Nagane

2 joint publications

Noriko Fukuhara